2Schreiber GB, Busch MP, Kleinman SH, et al. The risk of Transfusion-transmitted viral infection [J]. N Engl J med, 1996,334(5):1685-1690.
3Alverez M, Oyonarte S,Rodriglez PM,et al. Estimated risk of transfusion-transmitted virus infections in Spain [J]. Transfusion, 2002,42 (8) : 994-996.
4Velati C, Romano L,Baruffi L, et al. Residual risk of transfusion-transmitted HCV and HIV and HIV infection by antibodv-screened blood in ltaly [J]. Transfusion,2002,42 (8) :989-991.
5Roth WK, Weber M,Buhr S, et al. Yield of HCV and HIV-Ⅰ NAT after screening of 3.6 million blood donation in central Europe [J]. Transfusion, 2002,42 (7) : 862-866.
6Roth WK, Weber M,Petersen D, et al. NAT for HBV and anti-HBV testing increase bloodsafety[J]. Transfusion, 2002,42(7):869-872.
7Schottsted V, Tuma W, Bunger G, et al. PCR for HBV, HCV and HIV-Ⅰ experiences and first results form a routine screening programme in a large blood transfusion [J]. Service Biological, 1998,26 (2) : 101-104.
8Pillonel J ,Laperche S,Saura C, et al. Trends in residual risk of transfusion-transmitted viral infections in France between 1992 and 2000[J]. Transfusion, 2002, 42 (8) : 980-982.
9Dodd RY, Notari EP,Stramer SL, et al. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donorpoplation [J]. Transfusion, 2002, 42 (8) : 975-978.
10Seed CR, Cheng A, lsmay SL ,et al. Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Auatralia and the implications for future HBV NAT[J]. Transfusion, 2002,42 (10) : 1365-1367.
二级参考文献11
1李金明.定量聚合酶链反应测定技术[J].临床检验及实验设备,2001,1(1):11-12.
2Roth WK,Weber M,Seifried E. Feasibility and efficacy of rountine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Lancet, 1999,353:359-363
3Busch MP,Rawal BD,Nowicki M,et al.HCV RNA and ALT patterns in seroconverting transfusion recipients and correlation with donor ALT and RNA[].Transfusion.1997
4Vrielink H,Reesink HW,van den Burg PJM,et al.Performance of three generations of anti-hepatitis C virus ELISA in donors and patients[].Transfusion.1997
5Schottstedt V,Tuma W,Bunger G,et al.PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service[].Biologicals.1998
6Schreiber GB,Busch MP,Kleinman SH,et al.The risk of transfusiontransmitted viral infection[].The New England Journal of Medicine.1996
7Roth WK,Weber M,Seifried E.Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting[].The Lancet.1999
8Cardoso MS,Koerner K,Kubanek B,et al.Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results[].Transfusion.1998
